BACKGROUND: With increased scrutiny on the quality and cost of health care, surgeons must be mindful of their outcomes and resource use. We evaluated surgeon-specific intraoperative supply cost (ISC) for pancreaticoduodenectomy and examined whether ISC was associated with patient outcomes. STUDY DESIGN: Patients undergoing open pancreaticoduodenectomy between January 2012 and March 2015 were included. Outcomes were tracked prospectively through postoperative day 90, and ISC was defined as the facility cost of single-use surgical items and instruments, plus facility charges for multiuse equipment. Multivariate logistic regression was used to test associations between ISC and patient outcomes using repeated measures at the surgeon level. RESULTS: There were 249 patients who met inclusion criteria. Median ISC was $1,882 (interquartile range [IQR] $1,497 to $2,281). Case volume for 6 surgeons ranged from 18 to 66. Median surgeon-specific ISC ranged from $1,496 to $2,371. Greater case volume was associated with decreased ISC (p < 0.001). Overall, ISC was not predictive of postoperative complications (p = 0.702) or total hospitalization expenditures (p = 0.195). At the surgeon level, surgeon-specific ISC was not associated with the surgeon-specific incidence of severe complication or any wound infection (p > 0.227 for both), but was associated with delayed gastric emptying (p = 0.004) and postoperative pancreatic fistula (p < 0.001). CONCLUSIONS: In a single-institution cohort of 249 pancreaticoduodenectomies, high-volume surgeons tended to be low-cost surgeons. Across the cohort, ISC was not associated with outcomes. At the surgeon level, associations were noted between ISC and complications, but these may be attributable to unmeasured differences in the postoperative management of patients. These findings suggest that quality improvement efforts to restructure resource use toward more cost-effective practice may not affect patient outcomes, although prospective monitoring of safety and effectiveness must be of the utmost concern.
BACKGROUND: With increased scrutiny on the quality and cost of health care, surgeons must be mindful of their outcomes and resource use. We evaluated surgeon-specific intraoperative supply cost (ISC) for pancreaticoduodenectomy and examined whether ISC was associated with patient outcomes. STUDY DESIGN:Patients undergoing open pancreaticoduodenectomy between January 2012 and March 2015 were included. Outcomes were tracked prospectively through postoperative day 90, and ISC was defined as the facility cost of single-use surgical items and instruments, plus facility charges for multiuse equipment. Multivariate logistic regression was used to test associations between ISC and patient outcomes using repeated measures at the surgeon level. RESULTS: There were 249 patients who met inclusion criteria. Median ISC was $1,882 (interquartile range [IQR] $1,497 to $2,281). Case volume for 6 surgeons ranged from 18 to 66. Median surgeon-specific ISC ranged from $1,496 to $2,371. Greater case volume was associated with decreased ISC (p < 0.001). Overall, ISC was not predictive of postoperative complications (p = 0.702) or total hospitalization expenditures (p = 0.195). At the surgeon level, surgeon-specific ISC was not associated with the surgeon-specific incidence of severe complication or any wound infection (p > 0.227 for both), but was associated with delayed gastric emptying (p = 0.004) and postoperative pancreatic fistula (p < 0.001). CONCLUSIONS: In a single-institution cohort of 249 pancreaticoduodenectomies, high-volume surgeons tended to be low-cost surgeons. Across the cohort, ISC was not associated with outcomes. At the surgeon level, associations were noted between ISC and complications, but these may be attributable to unmeasured differences in the postoperative management of patients. These findings suggest that quality improvement efforts to restructure resource use toward more cost-effective practice may not affect patient outcomes, although prospective monitoring of safety and effectiveness must be of the utmost concern.
Authors: Jeffrey M Sutton; Gregory C Wilson; Koffi Wima; Richard S Hoehn; R Cutler Quillin; Dennis J Hanseman; Ian M Paquette; Jeffrey J Sussman; Syed A Ahmad; Shimul A Shah; Daniel E Abbott Journal: Ann Surg Oncol Date: 2015-04-04 Impact factor: 5.344
Authors: Matthew Gitelis; Yalini Vigneswaran; Michael B Ujiki; Woody Denham; Mark Talamonti; Joseph P Muldoon; John G Linn Journal: Am J Surg Date: 2014-12-17 Impact factor: 2.565
Authors: Brady R Still; Laura W Christianson; Julie M Mhlaba; Ian P O'Malley; David H Song; Alexander J Langerman Journal: J Reconstr Microsurg Date: 2016-10-12 Impact factor: 2.873
Authors: Jeffrey M Sutton; Gregory C Wilson; Ian M Paquette; Koffi Wima; Dennis J Hanseman; R Cutler Quillin; Jeffrey J Sussman; Michael J Edwards; Syed A Ahmad; Shimul A Shah; Daniel E Abbott Journal: HPB (Oxford) Date: 2014-07-16 Impact factor: 3.647
Authors: Yalini Vigneswaran; John G Linn; Matthew Gitelis; Joseph P Muldoon; Brittany Lapin; Woody Denham; Mark Talamonti; Michael B Ujiki Journal: J Am Coll Surg Date: 2015-03-14 Impact factor: 6.113
Authors: Jeffrey R Avansino; Adam B Goldin; Renelle Risley; John H T Waldhausen; Robert S Sawin Journal: J Pediatr Surg Date: 2013-09 Impact factor: 2.545
Authors: John D Birkmeyer; Cathryn Gust; Onur Baser; Justin B Dimick; Jason M Sutherland; Jonathan S Skinner Journal: Health Serv Res Date: 2010-12 Impact factor: 3.402
Authors: Ashwin S Balakrishnan; Lindsay A Hampson; Alexander M Bell; Arthur H Baghdanian; Armonde A Baghdanian; Maxwell V Meng; Anobel Y Odisho Journal: Transl Androl Urol Date: 2021-02